Filing Details
- Accession Number:
- 0001062993-25-004849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-06 21:08:33
- Reporting Period:
- 2025-03-04
- Filing Date:
- 2025-03-06
- Accepted Time:
- 2025-03-06 21:08:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661181 | Organogenesis Holdings Inc. | ORGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1912097 | Joseph Michael Driscoll | C/O Organogenesis Holdings Inc. 85 Dan Road Canton MA 02021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2025-03-04 | 25,000 | $5.10 | 166,879 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.33, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
